药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
Fendiline
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fendiline.
4-Bromo-2,5-dimethoxyamphetamine
Indenolol
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Indenolol.
4-Bromo-2,5-dimethoxyamphetamine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Bedaquiline.
4-Bromo-2,5-dimethoxyamphetamine
Antazoline
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Antazoline.
4-Bromo-2,5-dimethoxyamphetamine
Nilvadipine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nilvadipine.
4-Bromo-2,5-dimethoxyamphetamine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nemonoxacin.
4-Bromo-2,5-dimethoxyamphetamine
Telavancin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Telavancin.
4-Bromo-2,5-dimethoxyamphetamine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Tucidinostat.
4-Bromo-2,5-dimethoxyamphetamine
Tedisamil
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Tedisamil.
4-Bromo-2,5-dimethoxyamphetamine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Garenoxacin.
4-Bromo-2,5-dimethoxyamphetamine
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Technetium Tc-99m ciprofloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Pracinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Pracinostat.
4-Bromo-2,5-dimethoxyamphetamine
Azimilide
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Azimilide.
4-Bromo-2,5-dimethoxyamphetamine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fluspirilene.
4-Bromo-2,5-dimethoxyamphetamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Prenylamine.
4-Bromo-2,5-dimethoxyamphetamine
Terlipressin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Terlipressin.
4-Bromo-2,5-dimethoxyamphetamine
Aceprometazine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Aceprometazine.
4-Bromo-2,5-dimethoxyamphetamine
Probucol
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Probucol.
4-Bromo-2,5-dimethoxyamphetamine
Iron isomaltoside 1000
Iron isomaltoside 1000 can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.